ADMA Biologics Inc (ADMA)
21.18
-0.12
(-0.56%)
USD |
NASDAQ |
Nov 22, 16:00
21.21
+0.03
(+0.14%)
After-Hours: 20:00
ADMA Biologics Revenue (Annual): 258.22M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 258.22M |
| December 31, 2022 | 154.08M |
| December 31, 2021 | 80.94M |
| December 31, 2020 | 42.22M |
| December 31, 2019 | 29.35M |
| December 31, 2018 | 16.99M |
| Date | Value |
|---|---|
| December 31, 2017 | 22.76M |
| December 31, 2016 | 10.66M |
| December 31, 2015 | 7.178M |
| December 31, 2014 | 5.916M |
| December 31, 2013 | 3.068M |
| December 31, 2012 | 1.118M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
29.35M
Minimum
2019
258.22M
Maximum
2023
112.96M
Average
80.94M
Median
2021
Revenue (Annual) Benchmarks
| Corcept Therapeutics Inc | 482.38M |
| Madrigal Pharmaceuticals Inc | -- |
| Assembly Biosciences Inc | 7.163M |
| TG Therapeutics Inc | 233.66M |
| Krystal Biotech Inc | 50.70M |